These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 10226651)

  • 1. [Anticoagulation in atrial fibrillation before cardioversion].
    Stellbrink C; Hanrath P
    Dtsch Med Wochenschr; 1999 Apr; 124(13):407. PubMed ID: 10226651
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardioversion related thromboembolism: value of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation.
    Seidl K; Senges J
    Card Electrophysiol Rev; 2003 Dec; 7(4):392-6. PubMed ID: 15071262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Atrial fibrillation: novel possibilities of anticoagulant therapy in patients subjected to cardioversion].
    Averkov OV
    Kardiologiia; 2011; 51(7):53-7. PubMed ID: 21878086
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anticoagulation with low molecular weight heparins within the framework of cardioversion for atrial fibrillation].
    Tebbe U
    Dtsch Med Wochenschr; 2007 Sep; 132(39):2033-6. PubMed ID: 17882745
    [No Abstract]   [Full Text] [Related]  

  • 5. [Anticoagulation in cardioversion of atrial fibrillation. Current status and outlook for the future].
    Schimpf T; Stellbrink C
    Med Klin (Munich); 2003 Feb; 98(2):91-5. PubMed ID: 12601533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cardioversion in atrial fibrillation].
    Ricard P; Imianitoff M; Saoudi N
    Rev Prat; 2002 Jun; 52(12):1313-6. PubMed ID: 12187894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
    Stellbrink C; Nixdorff U; Hofmann T; Lehmacher W; Daniel WG; Hanrath P; Geller C; Mügge A; Sehnert W; Schmidt-Lucke C; Schmidt-Lucke JA;
    Circulation; 2004 Mar; 109(8):997-1003. PubMed ID: 14967716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: final results of a prospective 4.5-year study.
    Manning WJ; Silverman DI; Keighley CS; Oettgen P; Douglas PS
    J Am Coll Cardiol; 1995 May; 25(6):1354-61. PubMed ID: 7722133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Electrical cardioversion for non-valvular atrial fibrillation--underestimated risk for thromboembolic complications?].
    Klein HH
    Dtsch Med Wochenschr; 2013 Jun; 138(24):1309-11. PubMed ID: 23737116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct current cardioversion of atrial fibrillation--the next 40 years.
    Manning WJ; Zimetbaum PJ
    Mayo Clin Proc; 2002 Sep; 77(9):895-6. PubMed ID: 12233920
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevention of embolic events after cardioversion of atrial fibrillation. Current and evolving strategies.
    Kinch JW; Davidoff R
    Arch Intern Med; 1995 Jul; 155(13):1353-60. PubMed ID: 7794083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience in daily clinical practice of ambulatory cardioversion of atrial fibrillation treated with new oral anticoagulants.
    Santas E; Méndez J; Martínez-Brotons A; Núñez J; Chorro FJ; Ruiz-Granell R
    Rev Esp Cardiol (Engl Ed); 2014 Nov; 67(11):960-1. PubMed ID: 25242661
    [No Abstract]   [Full Text] [Related]  

  • 13. Spontaneous conversion in patients with non-valvular atrial fibrillation planned for electrical cardioversion: A subanalysis of the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion Of Atrial Fibrillation (ENSURE-AF) trial.
    Cohen AA; Heidbuchel H; Le Heuzey JY; De Caterina R; Merino JL; Jin J; Melino M; Winters SM; Goette A; Lip GYH
    Am Heart J; 2019 Mar; 209():131-135. PubMed ID: 30635112
    [No Abstract]   [Full Text] [Related]  

  • 14. Electrical and pharmacologic cardioversion for atrial fibrillation.
    Kim SS; Knight BP
    Cardiol Clin; 2009 Feb; 27(1):95-107, ix. PubMed ID: 19111767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-molecular-weight heparin in transesophageal echocardiography-guided cardioversion of atrial fibrillation.
    Wodlinger AM; Pieper JA
    Pharmacotherapy; 2003 Jan; 23(1):57-63. PubMed ID: 12523460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physician practices regarding anticoagulation and cardioversion of atrial fibrillation.
    Schlicht JR; Davis RC; Naqi K; Cooper W; Rao BV
    Arch Intern Med; 1996 Feb; 156(3):290-4. PubMed ID: 8572839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is early cardioversion of atrial fibrillation, facilitated by transesophageal echocardiography, safe and effective?
    Arthur M; Greenawald MH
    J Fam Pract; 2001 Nov; 50(11):925. PubMed ID: 11711003
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma fibrinogen and fibrin D-dimer in patients with atrial fibrillation: effects of cardioversion to sinus rhythm.
    Lip GY; Rumley A; Dunn FG; Lowe GD
    Int J Cardiol; 1995 Oct; 51(3):245-51. PubMed ID: 8586473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anticoagulation and electrical cardioversion of chronic atrial fibrillation: proposal for an abbreviated protocol].
    Antonielli E; Pizzuti A; Gandolfo N; Sclavo M; Tanga M; Riva G; Leonardi G; Bassignana A; Di Leo M
    G Ital Cardiol; 1997 Aug; 27(8):803-10. PubMed ID: 9312508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardioversion from atrial fibrillation without prolonged anticoagulation with use of transesophageal echocardiography to exclude the presence of atrial thrombi.
    Manning WJ; Silverman DI; Gordon SP; Krumholz HM; Douglas PS
    N Engl J Med; 1993 Mar; 328(11):750-5. PubMed ID: 8437595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.